UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000018163
Receipt No. R000021041
Official scientific title of the study An MEG study regarding the neural mechanisms of assessing the future level of fatigue.
Date of disclosure of the study information 2015/07/10
Last modified on 2016/07/04 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study An MEG study regarding the neural mechanisms of assessing the future level of fatigue.
Title of the study (Brief title) An MEG study regarding the neural mechanisms of assessing the future level of fatigue.
Region
Japan

Condition
Condition Healthy
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the neural mechanisms of assessing the future level of fatigue.
Basic objectives2 Others
Basic objectives -Others To investigate the neural mechanisms of fatigue
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The MEG data
Key secondary outcomes Questionnaires

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Behavior,custom
Interventions/Control_1 Cognitive task 1, Cognitive task 2
Interventions/Control_2 Cognitive task 2, Cognitive task 1
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
60 years-old >
Gender Male and Female
Key inclusion criteria Healthy adult
Key exclusion criteria Participants with past or current history of serious medical illness and/or brain organic disease, who take central nerve system acting drugs, who are contradicted for the use of MRI, and who are judged as not suitable for participation in this study.
Target sample size 20

Research contact person
Name of lead principal investigator Masaaki Tanaka
Organization Osaka City University Graduate School of Medicine
Division name Physiology
Address 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585
TEL 06-6645-3711
Email m5914885@msic.med.osaka-cu.ac.jp

Public contact
Name of contact person Akira Ishii
Organization Osaka City University Graduate School of Medicine
Division name Physiology
Address 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585
TEL 06-6645-3711
Homepage URL
Email a.ishii@med.osaka-cu.ac.jp

Sponsor
Institute Osaka City University Graduate School of Medicine
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization The Ministry of Education, Culture, Sports, Science and Technology of Japan
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪市立大学医学部附属病院(大阪), Osaka City University Hospital (Osaka)

Other administrative information
Date of disclosure of the study information
2015 Year 07 Month 10 Day

Progress
Recruitment status Main results already published
Date of protocol fixation
2015 Year 04 Month 20 Day
Anticipated trial start date
2015 Year 07 Month 10 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 07 Month 02 Day
Last modified on
2016 Year 07 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000021041